Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

MRNA

Moderna Inc

Nov 04 • 04:00PM ET

53.54

Dollar change -1.09
Percentage change -2.00	%

Healthcare • Biotechnology • USA • NASD

Peers: PFE BNTX NVAX JNJ AZN GSK MRK SNY LLY REGN

| Held by: VTI VOO VO QQQ VUG SPY IVV VOT XBI XLV

Scroll to Statements

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-15.38	Insider Own	10.83%	Shs Outstand	382.00M	Perf Week	-2.30%
Market Cap	20.68B	Forward P/E	-	EPS next Y	-8.62	Insider Trans	-1.06%	Shs Float	342.76M	Perf Month	-11.06%
Income	-5867.00M	PEG	-	EPS next Q	-1.94	Inst Own	67.99%	Short Float	9.70%	Perf Quarter	-34.95%
Sales	5.04B	P/S	4.10	EPS this Y	20.02%	Inst Trans	1.72%	Short Ratio	6.73	Perf Half Y	-56.16%
Book/sh	30.50	P/B	1.76	EPS next Y	12.57%	ROA	-31.24%	Short Interest	33.26M	Perf Year	-24.84%
Cash/sh	21.97	P/C	2.44	EPS next 5Y	-	ROE	-40.94%	52W Range	52.26 - 170.47	Perf YTD	-46.16%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-20.02%	ROI	-45.28%	52W High	-68.59%	Beta	1.67
Dividend TTM	-	Quick Ratio	3.92	Sales past 5Y	662.08%	Gross Margin	22.47%	52W Low	2.45%	ATR (14)	2.27
Dividend Ex-Date	-	Current Ratio	4.09	EPS Y/Y TTM	-601.75%	Oper. Margin	-92.09%	RSI (14)	30.85	Volatility	3.60% 3.56%
Employees	5600	Debt/Eq	0.11	Sales Y/Y TTM	-52.22%	Profit Margin	-116.36%	Recom	2.63	Target Price	90.67
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	8.04%	Payout	-	Rel Volume	0.81	Prev Close	54.63
Sales Surprise	87.68%	EPS Surprise	0.54%	Sales Q/Q	-29.94%	Earnings	Nov 07 BMO	Avg Volume	4.94M	Price	53.54
SMA20	-3.32%	SMA50	-16.52%	SMA200	-46.52%	Trades		Volume	4,020,893	Change	-2.00%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60
Aug-04-23	Downgrade	TD Cowen	Outperform → Market Perform	$145 → $125
Aug-03-23	Downgrade	Deutsche Bank	Buy → Hold	$125
Jul-24-23	Initiated	William Blair	Mkt Perform	$136.28
Jul-14-23	Initiated	HSBC Securities	Reduce	$97
Jun-26-23	Upgrade	UBS	Neutral → Buy	$221 → $191
Apr-26-23	Initiated	Guggenheim	Neutral
Mar-13-23	Upgrade	TD Cowen	Market Perform → Outperform	$150 → $180
Mar-02-23	Initiated	RBC Capital Mkts	Outperform	$200

Show Previous Ratings

Nov-04-24 09:16AM	Moderna (MRNA) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Oct-31-24 05:45PM	Moderna (MRNA) Stock Moves -0.66%: What You Should Know (Zacks)
02:52PM	Moderna (MRNA): Expanding Horizons in Gene Editing and mRNA Vaccines (Insider Monkey)
11:06AM	Is Moderna (NASDAQ:MRNA) Stock a Buy at Current Levels? (TipRanks)
10:02AM	Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for (Zacks)
07:00AM	Loading…
07:00AM	Moderna to Present at Upcoming Conferences in November 2024 (ACCESSWIRE)
Oct-30-24 01:53PM	Is Moderna, Inc. (MRNA) The Worst Performing S&P 500 Stock In 2024? (Insider Monkey)
01:52PM	Is Moderna Stock A Sell After The Company Slashed Its R&D Budget? (Investor's Business Daily)
Oct-29-24 05:50PM	Moderna (MRNA) Exceeds Market Returns: Some Facts to Consider (Zacks)
08:26AM	Moderna price target lowered to $60 from $105 at Evercore ISI (TipRanks)
06:28AM	Moderna and MSD begin trial of mRNA-4157 and Keytruda combination for lung cancer (Clinical Trials Arena)
Oct-28-24 12:45PM	Why Is Moderna Stock Trading Higher On Monday? (Benzinga)
09:48AM	Modernas Stock-Price Target Slashed. Its About Vaccines. (Barrons.com)
07:53AM	Moderna Stock Price Target Slashed. Its About Vaccines. (Barrons.com)
06:45AM	Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC) (Business Wire)
12:29PM	Loading…
Oct-26-24 12:29PM	Who Should Get Covid and Flu Vaccines This Yearand the Best Time to Get Them (Barrons.com)
12:29PM	Its Time to Get Your Covid and Flu Shots. Everything to Know About This Years Vaccines. (Barrons.com)
Oct-24-24 02:25PM	Moderna Named a Top Employer by Science for Tenth Consecutive Year (ACCESSWIRE)
04:00AM	Modernas norovirus vaccine enters Phase III trials in the UK (Clinical Trials Arena)
Oct-23-24 03:15PM	Moderna, Inc. (NASDAQ:MRNA) Isnt Seeing Any Love From Mutual Or Hedge Funds (Insider Monkey)
10:40AM	Moderna, Inc. (MRNA): Leading the Way in mRNA Vaccines and Respiratory Health (Insider Monkey)
08:00AM	Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence (PR Newswire)
Oct-21-24 05:50PM	Why Moderna (MRNA) Dipped More Than Broader Market Today (Zacks)
12:15PM	IDWeek 2024: Modernas norovirus vaccine mRNA-1403 shows potential in Phase I/II trial (Clinical Trials Arena)
Oct-20-24 02:17PM	Is Moderna Inc. (MRNA) the Best QQQ Stock to Buy According to Analysts? (Insider Monkey)
Oct-19-24 06:15PM	How Bad Is This News for Novavax? (Motley Fool)
11:19AM	Moderna, Inc. (MRNA): Worst Performing NASDAQ Stock in 2024 (Insider Monkey)
Oct-18-24 04:14PM	mRNA licensing agreements surge 800% amid GSK lawsuits (Pharmaceutical Technology)
03:26PM	Stryker Corporation (SYK): AI-Driven Innovations and Strategic Acquisitions Boost Growth (Insider Monkey)
Oct-17-24 07:05AM	Moderna to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 (ACCESSWIRE)
03:53PM	Loading…
Oct-16-24 03:53PM	Is Moderna, Inc. (MRNA) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
03:53PM	Moderna, Inc. (MRNA) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
06:59AM	GSK claims Moderna infringed mRNA vaccine patents (BioPharma Dive)
01:30AM	Use This Double Up Options Strategy to Cut Your Tax Bill (Barrons.com)
Oct-15-24 10:20AM	GSK sues Moderna for US patent infringement over COVID, RSV vaccines (Reuters)
Oct-14-24 05:50PM	Moderna (MRNA) Stock Sinks As Market Gains: Here's Why (Zacks)
Oct-12-24 08:30AM	2 Biotech Stocks That Are Screaming Buys This Month (Motley Fool)
Oct-11-24 08:00PM	Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock Even With Post-COVID Plans On The Table (Benzinga)
05:06PM	CDC Probes If Bird Flu Mutations Impact Vaccine Stockpile (Bloomberg)
Oct-10-24 10:47AM	Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna (Bloomberg)
Oct-09-24 08:00AM	Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month (Benzinga)
07:00AM	Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions (PR Newswire)
Oct-08-24 05:50PM	Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
05:45AM	Moderna, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA (PR Newswire)
Oct-07-24 10:59AM	Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies (Yahoo Finance)
Oct-05-24 07:56AM	Jim Cramer Reports That Moderna, Inc. (MRNA) Was Down Nearly 44% In The Third Quarter (Insider Monkey)
Oct-03-24 08:00AM	Invaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors (PR Newswire)
05:00AM	Eli Lilly, Moderna and more: The 5 highest paid healthcare CEOs (Quartz)
Oct-02-24 07:00AM	Abbas Hussain Joins Moderna's Board of Directors (ACCESSWIRE)
05:00AM	Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now (Quartz)
04:46AM	Is It Time to Buy September's Worst-Performing S&P 500 Stocks? (Motley Fool)
Oct-01-24 02:11PM	The Covid Era Tech Promises To Reinvent Cancer Treatment (Benzinga)
10:33AM	Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip? (Insider Monkey)
08:00AM	IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply (BioPharma Dive)
04:32AM	Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US (Clinical Trials Arena)
Sep-30-24 08:00PM	Moderna and Cenra Healthcare Enter Joint Agreement to Promote Modernas mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines (ACCESSWIRE)
05:50PM	Moderna (MRNA) Rises Higher Than Market: Key Facts (Zacks)
07:00AM	Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403 (ACCESSWIRE)
Sep-28-24 09:45PM	Moderna Inc (NASDAQ:MRNA): Jim Cramer Is Disappointed (Insider Monkey)
07:30AM	3 Surprisingly Underrated Stocks to Buy Right Now (Motley Fool)
Sep-26-24 10:53AM	Moderna blamed after children offered £1,500 to take part in Covid-19 trial (Clinical Trials Arena)
06:00AM	Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry (PR Newswire)
Sep-25-24 11:13AM	As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech (Clinical Trials Arena)
Sep-24-24 05:50PM	Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Sep-23-24 02:00PM	Top 3 Health Care Stocks That May Explode This Month (Benzinga)
06:00AM	2 Beaten-Down Stocks to Buy and Hold for a Decade (Motley Fool)
Sep-20-24 10:48AM	Pfizer Advances On Its Cancer Journey (Benzinga)
05:52AM	Down 13% in 1 Day, Is Moderna Stock in Trouble? (Motley Fool)
03:08AM	Jim Cramer Says Moderna Inc. (MRNA) Has Been A Big Disappointment (Insider Monkey)
Sep-19-24 01:29PM	Investors in Moderna, Inc. Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights MRNA (GlobeNewswire)
12:02PM	BioNTech Is More Than a Covid-19 Stock. Its Having a Great September. (Barrons.com)
06:50AM	Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks (Motley Fool)
05:12AM	Mpox: Three ongoing vaccine trials to watch (Clinical Trials Arena)
Sep-18-24 05:49AM	Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 (Motley Fool)
Sep-17-24 11:27PM	Jim Cramer Says Moderna, Inc. (MRNA)'s Vaccine Pipeline and Cancer Advances Make It a Strong Buy (Insider Monkey)
05:07PM	S&P 500 Gains and Losses Today: New Home Battery, Software Lift Enphase Stock (Investopedia)
03:46PM	Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine (Investopedia)
11:00AM	Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older (ACCESSWIRE)
06:33AM	FDA OKs third dose for Pfizer and Moderna Covid-19 vaccines (Pharmaceutical Technology)
Sep-16-24 05:50PM	Moderna (MRNA) Rises Higher Than Market: Key Facts (Zacks)
11:18AM	DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions (Benzinga)
09:08AM	Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day (Investor's Business Daily)
08:56AM	Moderna Crashes After Slashing Its R&D Budget, Issuing Light Guidance (Investor's Business Daily)
Sep-15-24 08:20AM	Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path? (Motley Fool)
03:00AM	Worlds Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna (Barrons.com)
Sep-14-24 04:20AM	After Moderna's Shocking News, Is the Stock a Buy or a Sell? (Motley Fool)
Sep-13-24 06:34PM	Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target (Benzinga)
05:03PM	Why Moderna's delayed break-even goal may not even be possible (Yahoo Finance Video)
03:26PM	Moderna Stock Keeps Falling. An Analyst's Downgrade Isn't Helping (Investopedia)
02:18PM	Midday stock movers: Adobe, Boeing, Moderna (TheStreet)
12:54PM	Top Stock Movers Now: Uber, Adobe, Etsy, and More (Investopedia)
09:59AM	Moderna stock slides on downgrades tied to profitability delay (Yahoo Finance Video)
09:33AM	Moderna, Halliburton downgraded: Wall Street's top analyst calls (The Fly)
09:09AM	Moderna Stock Falls Again. How the Drug Maker Can Turn Things Around. (Barrons.com)
08:42AM	Analyst Report: Moderna, Inc. (Morningstar Research)
07:30AM	A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now (Motley Fool)
06:12AM	ESMO: Modernas mRNA solid tumour vaccine shows early promise (Clinical Trials Arena)
05:45AM	Moderna shares slip premarket as analysts cut ratings amid guidance worries (Investing.com)
Sep-12-24 05:19PM	Modernas CEO Sees an Evolution of Strategy. The Stock Hits Lowest Level Since 2020. (Barrons.com) -12.36%
05:13PM	Moderna Stock Falls 12% After Vaccine Maker Cuts R&D Plans, Drugs Pipeline (The Wall Street Journal)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mock James M	Chief Financial Officer	Oct 07 '24	Sale	60.12	715	42,986	9,505	Oct 08 04:19 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 09 '24	Sale	73.57	551	40,539	18,154	Sep 10 04:15 PM
Klinger Shannon Thyme	Officer	Sep 09 '24	Proposed Sale	73.57	551	40,539		Sep 09 03:29 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 03 '24	Sale	76.99	114	8,777	17,566	Sep 04 05:42 PM
Hoge Stephen	President	Sep 03 '24	Sale	76.99	318	24,483	1,443,002	Sep 04 04:26 PM
Klinger Shannon Thyme	Officer	Sep 03 '24	Proposed Sale	76.99	114	8,777		Sep 03 03:58 PM
Hoge Stephen	Officer	Sep 03 '24	Proposed Sale	76.99	318	24,482		Sep 03 03:42 PM
Mock James M	Chief Financial Officer	Aug 29 '24	Sale	78.03	162	12,640	8,767	Aug 30 04:37 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 29 '24	Sale	78.03	162	12,640	17,447	Aug 30 04:34 PM
Hoge Stephen	President	Aug 29 '24	Sale	78.03	300	23,408	1,442,668	Aug 30 04:32 PM
Mock James M	Chief Financial Officer	Aug 28 '24	Sale	79.39	1,321	104,881	8,600	Aug 29 04:45 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 28 '24	Sale	79.39	1,319	104,722	17,280	Aug 29 04:03 PM
Klinger Shannon Thyme	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:52 PM
Mock James M	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:43 PM
Hoge Stephen	Officer	Aug 29 '24	Proposed Sale	78.03	300	23,408		Aug 29 03:38 PM
Mock James M	Officer	Aug 28 '24	Proposed Sale	79.39	1,321	104,881		Aug 28 04:47 PM
Klinger Shannon Thyme	Officer	Aug 28 '24	Proposed Sale	79.39	1,319	104,722		Aug 28 04:30 PM
Hoge Stephen	President	Aug 12 '24	Sale	84.10	254	21,363	1,442,357	Aug 13 04:33 PM
Hoge Stephen	Officer	Aug 12 '24	Proposed Sale	84.10	254	21,363		Aug 12 04:05 PM
AFEYAN NOUBAR	Director	Jul 31 '24	Sale	119.96	15,000	1,799,443	2,224,015	Aug 02 07:00 PM
NOUBAR B AFEYAN	Director	Jul 31 '24	Proposed Sale	118.84	15,000	1,782,600		Jul 31 04:18 PM
AFEYAN NOUBAR	Director	Jul 24 '24	Sale	117.80	15,000	1,766,972	2,239,015	Jul 26 07:00 PM
AFEYAN NOUBAR	Director	Jul 17 '24	Sale	122.84	15,000	1,842,651	2,254,015	Jul 19 07:00 PM
Hoge Stephen	President	Jul 15 '24	Sale	121.12	15,000	1,816,800	1,442,089	Jul 16 04:08 PM
AFEYAN NOUBAR	Director	Jul 10 '24	Sale	117.08	15,000	1,756,177	2,269,015	Jul 12 07:00 PM
Mock James M	Chief Financial Officer	Jul 08 '24	Sale	118.24	689	81,465	7,269	Jul 09 04:34 PM
AFEYAN NOUBAR	Director	Jun 26 '24	Sale	127.22	15,000	1,908,293	2,284,015	Jun 28 07:00 PM
AFEYAN NOUBAR	Director	Jun 18 '24	Sale	133.57	15,000	2,003,561	2,299,015	Jun 21 07:00 PM
Hoge Stephen	President	Jun 17 '24	Sale	138.16	15,000	2,072,400	1,457,089	Jun 18 04:05 PM
AFEYAN NOUBAR	Director	Jun 12 '24	Sale	147.20	15,000	2,208,071	2,314,015	Jun 14 07:00 PM
AFEYAN NOUBAR	Director	Jun 11 '24	Sale	148.34	202,832	30,087,339	1,528,557	Jun 11 07:01 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 10 '24	Sale	148.09	5,178	766,785	15,947	Jun 11 04:05 PM
AFEYAN NOUBAR	Director	Jun 05 '24	Sale	151.25	15,000	2,268,804	1,946,931	Jun 07 07:00 PM
Mock James M	Chief Financial Officer	Jun 03 '24	Sale	140.72	691	97,237	6,506	Jun 04 05:27 PM
Hoge Stephen	President	Jun 03 '24	Sale	140.72	339	47,704	1,472,089	Jun 04 05:20 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 03 '24	Sale	140.72	122	17,168	10,878	Jun 04 05:12 PM
AFEYAN NOUBAR	Director	May 29 '24	Sale	145.08	20,000	2,901,585	1,961,931	May 31 07:00 PM
Mock James M	Chief Financial Officer	May 29 '24	Sale	144.50	183	26,444	5,871	May 30 04:36 PM
Klinger Shannon Thyme	Chief Legal Officer	May 29 '24	Sale	144.50	183	26,444	10,768	May 30 04:27 PM
Hoge Stephen	President	May 29 '24	Sale	144.50	341	49,276	1,471,777	May 30 04:14 PM
Mock James M	Chief Financial Officer	May 28 '24	Sale	162.47	648	105,283	5,726	May 29 04:16 PM
Klinger Shannon Thyme	Chief Legal Officer	May 28 '24	Sale	162.47	1,296	210,566	10,623	May 29 04:12 PM
AFEYAN NOUBAR	Director	May 22 '24	Sale	157.57	15,000	2,363,556	1,981,931	May 24 07:00 PM
AFEYAN NOUBAR	Director	May 15 '24	Sale	127.32	15,000	1,909,863	1,996,931	May 17 07:00 PM
Hoge Stephen	President	May 15 '24	Sale	127.49	15,000	1,912,350	1,471,508	May 17 04:04 PM
Hoge Stephen	President	May 10 '24	Sale	120.96	255	30,844	1,486,508	May 13 04:03 PM
AFEYAN NOUBAR	Director	May 08 '24	Sale	121.68	15,000	1,825,220	2,011,931	May 10 07:00 PM
AFEYAN NOUBAR	Director	May 01 '24	Sale	110.92	15,000	1,663,855	2,026,931	May 03 07:00 PM
AFEYAN NOUBAR	Director	Apr 24 '24	Sale	108.32	15,000	1,624,836	2,041,931	Apr 26 07:00 PM
AFEYAN NOUBAR	Director	Apr 17 '24	Sale	103.38	15,000	1,550,703	2,056,931	Apr 19 07:00 PM
Hoge Stephen	President	Apr 15 '24	Sale	105.02	15,000	1,575,300	1,486,241	Apr 16 04:23 PM
AFEYAN NOUBAR	Director	Apr 10 '24	Sale	107.12	15,000	1,606,865	2,071,931	Apr 12 07:00 PM
Mock James M	Chief Financial Officer	Apr 08 '24	Sale	101.93	705	71,859	5,048	Apr 09 04:09 PM
AFEYAN NOUBAR	Director	Apr 03 '24	Sale	101.68	15,000	1,525,268	2,086,931	Apr 05 07:00 PM
AFEYAN NOUBAR	Director	Mar 27 '24	Sale	109.06	15,000	1,635,864	2,101,931	Mar 29 07:00 PM
AFEYAN NOUBAR	Director	Mar 20 '24	Sale	102.39	15,000	1,535,820	2,116,931	Mar 22 07:00 PM
Hoge Stephen	President	Mar 15 '24	Sale	103.17	15,000	1,547,550	1,501,241	Mar 19 04:39 PM
AFEYAN NOUBAR	Director	Mar 13 '24	Sale	108.54	15,000	1,628,031	2,131,931	Mar 15 07:00 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 08 '24	Sale	99.05	544	53,884	9,267	Mar 11 09:05 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 04 '24	Sale	94.34	117	11,038	8,673	Mar 05 05:56 PM
Hoge Stephen	President	Mar 04 '24	Sale	94.34	309	29,151	1,516,241	Mar 05 05:52 PM
Mock James M	Chief Financial Officer	Feb 29 '24	Sale	94.57	647	61,188	4,300	Mar 01 05:33 PM
Klinger Shannon Thyme	Chief Legal Officer	Feb 29 '24	Sale	94.57	670	63,363	8,557	Mar 01 05:29 PM
Hoge Stephen	President	Feb 29 '24	Sale	94.57	2,388	225,838	1,515,898	Mar 01 05:25 PM
Hoge Stephen	President	Feb 22 '24	Sale	100.00	15,000	1,500,000	1,513,433	Feb 23 04:04 PM
Hoge Stephen	President	Feb 16 '24	Sale	88.88	10,542	936,981	1,528,433	Feb 16 04:19 PM
Bancel Stephane	Chief Executive Officer	Feb 16 '24	Sale	88.88	26,351	2,342,098	5,460,224	Feb 16 04:10 PM
Hoge Stephen	President	Feb 12 '24	Sale	86.23	304	26,214	1,516,281	Feb 13 04:13 PM
Hoge Stephen	President	Jan 16 '24	Sale	103.90	15,000	1,558,500	1,516,063	Jan 17 04:12 PM
Mock James M	Chief Financial Officer	Jan 08 '24	Sale	109.75	772	84,731	3,632	Jan 09 04:08 PM
Hoge Stephen	President	Dec 27 '23	Sale	100.01	45,000	4,500,450	1,531,063	Dec 28 08:00 AM
Klinger Shannon Thyme	Chief Legal Officer	Dec 08 '23	Sale	79.09	563	44,525	7,912	Dec 11 04:03 PM
Garay Arpa	Chief Commercial Officer	Dec 06 '23	Sale	78.34	564	44,182	3,690	Dec 07 04:21 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 04 '23	Sale	79.31	111	8,804	7,336	Dec 05 04:10 PM
Hoge Stephen	President	Dec 04 '23	Sale	79.31	309	24,508	1,576,063	Dec 05 04:07 PM
Hoge Stephen	President	Nov 29 '23	Sale	79.81	1,136	90,666	1,575,721	Nov 30 04:11 PM
Hoge Stephen	President	Nov 10 '23	Sale	68.76	263	18,084	1,574,446	Nov 13 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience